Literature DB >> 5463901

The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.

I H Stevenson, M J Turnbull.   

Abstract

1. The sensitivity of the central nervous system to barbiturate was determined in rats during the chronic administration of barbitone sodium and after its withdrawal.2. The brain barbiturate concentration determined on awakening from a hypnotic dose administered intraperitoneally was found to increase throughout the period of barbitone administration.3. A similar gradual development of central nervous system tolerance was indicated by measuring the duration of anaesthesia following an intraventricular injection of pentobarbitone.4. The change in sensitivity of the brain which occurred during the period of barbitone administration was not demonstrable from the measurement of sleeping time following intraperitoneal injection of barbitone or pentobarbitone.5. After withdrawal, the sensitivity of the brain to barbiturate gradually returned to normal.6. It was concluded that the hypersensitivity to pentobarbitone, but not to barbitone, which develops after withdrawal of barbitone sodium is due to a decreased drug-metabolizing capacity.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5463901      PMCID: PMC1702835          DOI: 10.1111/j.1476-5381.1970.tb12896.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  The fate of pentobarbital in man and dog and a method for its estimation in biological material.

Authors:  B B BRODIE; J J BURNS; L C MARK; P A LIEF; E BERNSTEIN; E M PAPPER
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

2.  The effect of chronic barbitone administration and withdrawal on the sensitivity of the central nervous system to barbiturate.

Authors:  I H Stevenson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

3.  Hepatic drug-metabolising enzyme activity and duration of hexobarbitone anaesthesia in barbitone-dependent and withdrawn rats.

Authors:  I H Stevenson; M J Turnbull
Journal:  Biochem Pharmacol       Date:  1968-11       Impact factor: 5.858

4.  A sensitive method for the determination and isolation of pentobarbital-C14 metabolites and its application to in vitro studies of drug metabolism.

Authors:  R Kuntzman; M Ikeda; M Jacobson; A H Conney
Journal:  J Pharmacol Exp Ther       Date:  1967-07       Impact factor: 4.030

5.  Latent hypersensitivity to pentobarbital in the rat.

Authors:  R Aston
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

6.  A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain.

Authors:  E P Noble; R J Wurtman; J Axelrod
Journal:  Life Sci       Date:  1967-02-01       Impact factor: 5.037

7.  Induced hypersensitivity to barbital in the female rat.

Authors:  R Aston; P Hibbeln
Journal:  Science       Date:  1967-09-22       Impact factor: 47.728

  7 in total
  5 in total

1.  Proceedings: The use of halothane-induced sleeping time as an index of central nervous system excitability.

Authors:  M J Turnbull; J W Watkins
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Some observations on the mechanism of benzodiazepine-barbiturate interactions in the mouse.

Authors:  D M Chambers; G C Jefferson
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

3.  Mechanisms contributing to barbiturate intolerance in rats.

Authors:  R Aston
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

4.  Determination of halothane-induced sleeping time in the rat: effect of prior administration of centrally active drugs.

Authors:  M J Turnbull; J W Watkins
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

5.  A study of the factors affecting the sleeping time following intracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally active drugs.

Authors:  I H Stevenson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.